INTECH Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

INTECH Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.9M	Buy	35,018 +27,318	+355%	+$2.19M	0.03%	562
2026 Q1	$592K	Sell	7,700 -30,808	-80%	-$2.4M	0.01%	1260
2025 Q4	$3.04M	Buy	38,508 +10,975	+40%	+$950K	0.03%	552
2025 Q3	$2.52M	Buy	27,533 +616	+2%	+$50.2K	0.02%	649
2025 Q2	$1.76M	Buy	26,917 +15,447	+135%	+$1.01M	0.02%	845
2025 Q1	$768K	Sell	11,470 -6,310	-35%	-$377K	0.01%	1368
2024 Q4	$983K	Buy	17,780 +5,187	+41%	+$298K	0.01%	1155
2024 Q3	$751K	Buy	+12,593	New	+$768K	0.01%	981

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's ANIP Position: Q2 2026 in Review

INTECH Investment Management increased its ANI Pharmaceuticals (ANIP) stake by 355% in Q2 2026, buying an estimated $2.19M and bringing the position to 35,018 shares worth $2.9M. The position accounts for 0.03% of the portfolio, ranked #562.

INTECH Investment Management first reported a position in ANIP in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.04M in Q4 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

INTECH Investment Management held 35,018 shares of ANI Pharmaceuticals worth $2.9M as of Q2 2026.
INTECH Investment Management bought 27,318 ANI Pharmaceuticals shares in Q2 2026, an estimated $2.19M.
ANI Pharmaceuticals made up 0.03% of INTECH Investment Management's portfolio in Q2 2026, its #562 holding.
INTECH Investment Management first reported a position in ANI Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's ANI Pharmaceuticals position peaked at $3.04M in Q4 2025.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.